Suppr超能文献

黄芩对癌细胞增殖和前列腺素E2合成的抑制作用。

Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis.

作者信息

Zhang David Y, Wu Josephine, Ye Fei, Xue Li, Jiang Shiquan, Yi Jizu, Zhang Wandi, Wei Huachen, Sung Max, Wang Wayne, Li Xiaoping

机构信息

Department of Pathology, Mount Sinai School of Medicine, New York University, New York, New York 10029, USA.

出版信息

Cancer Res. 2003 Jul 15;63(14):4037-43.

Abstract

Scutellaria baicalensis is a widely used Chinese herbal medicine that has been used historically in anti-inflammatory and anticancer therapy. The purpose of this study is to verify its anticancer activity on head and neck squamous cell carcinoma (HNSCC) in vitro and in vivo and to investigate its effect on cyclooxygenase-2 (COX-2), which converts arachidonic acid to prostaglandin E(2) (PGE(2)) and is highly expressed in HNSCC. Two human HNSCC cell lines (SCC-25 and KB) and a nontumorigenic cell line (HaCaT) were tested in vitro for growth inhibition, proliferation cell nuclear antigen expression, and COX-2 activity and expression after treatment with Scutellaria baicalensis extract. Its effects were compared with those of baicalein (a flavonoid isolated from Scutellaria baicalensis), indomethacin (a nonselective COX inhibitor), and celecoxib (a selective COX-2 inhibitor). Four nude mice with s.c. inoculation of KB cells were tested for its anticancer activity in vivo by oral administration of Scutellaria baicalensis at a dose of 1.5 mg/mouse (75 mg/kg), five times/week for 7 weeks. Scutellaria baicalensis and other agents demonstrated a strong growth inhibition in both tested human HNSCC cell lines. No growth inhibition of HaCaT cells was observed with Scutellaria baicalensis. The IC(50)s were 150 micro g/ml for Scutellaria baicalensis, 25 micro M for celecoxib, and 75 micro M for baicalein and indomethacin. Scutellaria baicalensis, as well as celecoxib and indomethacin, but not baicalein, suppressed proliferation cell nuclear antigen expression and PGE(2) synthesis in both cell types. Scutellaria baicalensis inhibited COX-2 expression, whereas celecoxib inhibited COX-2 activity directly. A 66% reduction in tumor mass was observed in the nude mice. Scutellaria baicalensis selectively and effectively inhibits cancer cell growth in vitro and in vivo and can be an effective chemotherapeutic agent for HNSCC. Inhibition of PGE(2) synthesis via suppression of COX-2 expression may be responsible for its anticancer activity. Differences in biological effects of Scutellaria baicalensis compared with baicalein suggest the synergistic effects among components in Scutellaria baicalensis.

摘要

黄芩是一种广泛应用的中草药,历史上一直用于抗炎和抗癌治疗。本研究的目的是在体外和体内验证其对头颈鳞状细胞癌(HNSCC)的抗癌活性,并研究其对环氧化酶-2(COX-2)的影响,COX-2可将花生四烯酸转化为前列腺素E2(PGE2),在HNSCC中高表达。用人HNSCC细胞系(SCC-25和KB)和非致瘤细胞系(HaCaT)在体外检测黄芩提取物处理后的生长抑制、增殖细胞核抗原表达以及COX-2活性和表达。将其作用与黄芩苷(从黄芩中分离出的一种黄酮类化合物)、吲哚美辛(一种非选择性COX抑制剂)和塞来昔布(一种选择性COX-2抑制剂)的作用进行比较。对4只皮下接种KB细胞的裸鼠口服给予黄芩,剂量为1.5mg/只(75mg/kg),每周5次,共7周,检测其体内抗癌活性。黄芩和其他药物在两种受试人HNSCC细胞系中均表现出强烈的生长抑制作用。黄芩未观察到对HaCaT细胞的生长抑制作用。黄芩的半数抑制浓度(IC50)为150μg/ml,塞来昔布为25μM,黄芩苷和吲哚美辛为75μM。黄芩以及塞来昔布和吲哚美辛,但不是黄芩苷,在两种细胞类型中均抑制增殖细胞核抗原表达和PGE2合成。黄芩抑制COX-2表达,而塞来昔布直接抑制COX-2活性。在裸鼠中观察到肿瘤质量减少了66%。黄芩在体外和体内选择性且有效地抑制癌细胞生长,可成为HNSCC的有效化疗药物。通过抑制COX-2表达来抑制PGE2合成可能是其抗癌活性的原因。与黄芩苷相比,黄芩生物学效应的差异表明黄芩中各成分之间存在协同作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验